🇺🇸 FDA
Patent

US 10266560

Bile acid analogs as FXR/TGR5 agonists and methods of use thereof

granted A61PA61P1/00A61P1/16

Quick answer

US patent 10266560 (Bile acid analogs as FXR/TGR5 agonists and methods of use thereof) held by Enanta Pharmaceuticals, Inc. expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Enanta Pharmaceuticals, Inc.
Grant date
Tue Apr 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61P, A61P1/00, A61P1/16, A61P13/12, A61P3/00